Pier Capital, LLC Roivant Sciences Ltd. Call Options Transaction History
Pier Capital, LLC
- $714 Million
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ROIV
# of Institutions
270Shares Held
488MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$785 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$746 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$717 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$389 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$383 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.57B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...